Most psoriasis patients can safely reduce their dosage of biologics
Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half.
Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half.